Internal Medicine · Camillus, NY
NPI
1871609974
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
5417 W Genesee St
Camillus, NY, 13031
Phone (315) 475-2323
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
2,237 services
Medicare patients, 2024
401
Average age 80
Drug cost, 2024
$970K
8,283 prescriptions
Company payments, 2025
$1,351
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Albert T Tripodi was code 99214 (office e&m - established), 470 times for 231 patients. In total Albert T Tripodi billed 2,237 services in 33 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 470 | 231 | $79.81 | $38K |
| 99308 SNF E&M | Facility | 320 | 106 | $53.37 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 305 | 182 | $11.08 | $3,380 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 180 | 180 | $123.05 | $22K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 135 | 135 | $17.71 | $2,390 |
| 36415 Venipuncture Blood Collection | Office | 110 | 69 | $8.65 | $952 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 98 | 25 | $43.97 | $4,309 |
| 99305 SNF E&M | Facility | 90 | 81 | $99.04 | $8,914 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 82 | 20 | $34.60 | $2,837 |
| 99213 Office E&M - Established | Office | 72 | 59 | $56.65 | $4,079 |
| 93000 Electrocardiogram | Office | 31 | 31 | $9.32 | $289 |
| G0009 Administration of pneumococcal vaccine | Office | 20 | 20 | $26.07 | $521 |
| 90677 Vaccine Product | Office | 20 | 20 | $276.56 | $5,531 |
| G0008 Administration of influenza virus vaccine | Office | 18 | 18 | $27.44 | $494 |
| 90653 Vaccine Product | Office | 18 | 18 | $77.27 | $1,391 |
By year: 2022 $130K for 2,203 services; 2023 $114K for 1,811 services; 2024 $117K for 2,237 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 110 | 69 | $8.65 | $952 |
Medicare prescription drug claims, 2024
In 2024, the drug Albert T Tripodi prescribed most often to Medicare patients was Atorvastatin Calcium, with 580 prescriptions and refills. In total Albert T Tripodi wrote 8,283 Medicare prescriptions that cost $970K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 580 | 1,623 | 163 | $6,107 |
| Amlodipine Besylate Generic | 419 | 995 | 104 | $2,472 |
| Lisinopril Generic | 311 | 675 | 62 | $1,765 |
| Levothyroxine Sodium Generic | 300 | 790 | 79 | $6,385 |
| Omeprazole Generic | 242 | 573 | 69 | $3,051 |
| Ramipril Generic | 230 | 652 | 66 | $3,741 |
| Hydrochlorothiazide Generic | 210 | 612 | 58 | $948 |
| Gabapentin Generic | 187 | 271 | 38 | $1,731 |
| Eliquis Apixaban | 165 | 270 | 32 | $144K |
| Metformin Hcl Generic | 163 | 469 | 45 | $1,712 |
| Escitalopram Oxalate Generic | 161 | 298 | 31 | $936 |
| Metoprolol Succinate Generic | 157 | 421 | 45 | $2,304 |
| Losartan Potassium Generic | 128 | 372 | 38 | $1,259 |
| Rosuvastatin Calcium Generic | 127 | 375 | 42 | $2,094 |
| Sertraline Hcl Generic | 119 | 243 | 33 | $1,006 |
Brand drugs: 1,156 claims; generic drugs: 7,059 claims; opioid claims: 216.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Albert T Tripodi $1,351 ($1,351 in general payments such as food, travel and fees) from 22 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $301.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $301 |
| Pfizer Inc. PFE | 13 | $173 |
| Amgen Inc. AMGN | 12 | $148 |
| GlaxoSmithKline, LLC. GSK | 5 | $140 |
| Corcept Therapeutics CORT | 3 | $81.41 |
| Exact Sciences Corporation EXAS | 2 | $53.08 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $48.8 |
| Phathom Pharmaceuticals, Inc. PHAT | 4 | $47.29 |
| Merck Sharp & Dohme LLC MRK | 3 | $45.79 |
| Novo Nordisk Inc NVO | 2 | $39.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.